Trial intelligence / Profile preview

Aleph Inactivated Split Influenza Vaccine Safety and Immunogenicity Study

NCT01758185Phase 4Completed

Sponsor
Beijing Center for Disease Control and Prevention
Start
Aug 2011
Primary completion
Nov 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of Aleph influenza vaccine in influenza, sponsored by Beijing Center for Disease Control and Prevention. Started Aug 2011; status: completed.

02

Drugs

Aleph influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01758185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01758185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call